Variant report
Variant | esv3349837 |
---|---|
Chromosome Location | chr7:14053527-14057025 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:30)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:30 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CUX1 | chr7:14053531-14053622 | K562 | blood: | n/a | n/a |
2 | EP300 | chr7:14053853-14053858 | GM12878 | blood: | n/a | n/a |
3 | EP300 | chr7:14056462-14057121 | SK-N-SH | brain: | n/a | n/a |
4 | EP300 | chr7:14053478-14053917 | SK-N-SH_RA | brain: | n/a | chr7:14053855-14053864 chr7:14053856-14053865 |
5 | EP300 | chr7:14053489-14053981 | SK-N-SH_RA | brain: | n/a | chr7:14053855-14053864 chr7:14053856-14053865 chr7:14053964-14053978 |
6 | EP300 | chr7:14053460-14053963 | SK-N-SH | brain: | n/a | chr7:14053855-14053864 chr7:14053856-14053865 |
7 | EP300 | chr7:14053561-14053584 | GM12878 | blood: | n/a | n/a |
8 | FOSL2 | chr7:14053539-14054123 | SK-N-SH | brain: | n/a | chr7:14053856-14053864 chr7:14053855-14053864 chr7:14053857-14053864 chr7:14053856-14053865 |
9 | GATA3 | chr7:14054675-14054834 | SH-SY5Y | brain: | n/a | n/a |
10 | GATA3 | chr7:14053116-14054131 | SK-N-SH | brain: | n/a | n/a |
11 | GATA3 | chr7:14056454-14057136 | SK-N-SH | brain: | n/a | n/a |
12 | GATA3 | chr7:14056406-14057207 | SK-N-SH | brain: | n/a | n/a |
13 | GATA3 | chr7:14053344-14054120 | SK-N-SH | brain: | n/a | n/a |
14 | IRF1 | chr7:14056133-14056157 | K562 | blood: | n/a | n/a |
15 | JUND | chr7:14056486-14057029 | SK-N-SH | brain: | n/a | chr7:14056540-14056549 |
16 | JUND | chr7:14053454-14054117 | SK-N-SH | brain: | n/a | chr7:14053856-14053864 chr7:14053855-14053864 chr7:14053857-14053864 chr7:14053856-14053865 |
17 | JUND | chr7:14053373-14054085 | SK-N-SH | brain: | n/a | chr7:14053856-14053864 chr7:14053855-14053864 chr7:14053857-14053864 chr7:14053856-14053865 |
18 | NFIC | chr7:14056490-14057086 | SK-N-SH | brain: | n/a | n/a |
19 | PBX3 | chr7:14053307-14054134 | SK-N-SH | brain: | n/a | n/a |
20 | PBX3 | chr7:14056471-14057103 | SK-N-SH | brain: | n/a | n/a |
21 | PBX3 | chr7:14053489-14053941 | SK-N-SH | brain: | n/a | n/a |
22 | PBX3 | chr7:14056526-14057022 | SK-N-SH | brain: | n/a | n/a |
23 | POLR2A | chr7:14056017-14056185 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | POLR2A | chr7:14053523-14053833 | SK-N-SH | brain: | n/a | n/a |
25 | POLR2A | chr7:14051050-14054394 | K562 | blood: | n/a | n/a |
26 | POLR2A | chr7:14054603-14055731 | K562 | blood: | n/a | n/a |
27 | TCF12 | chr7:14056397-14057171 | SK-N-SH | brain: | n/a | chr7:14056808-14056816 chr7:14057023-14057032 |
28 | TCF12 | chr7:14053364-14053990 | SK-N-SH | brain: | n/a | chr7:14053399-14053409 |
29 | TCF12 | chr7:14053352-14054043 | SK-N-SH | brain: | n/a | chr7:14053399-14053409 |
30 | TCF12 | chr7:14056480-14057036 | SK-N-SH | brain: | n/a | chr7:14056808-14056816 chr7:14057023-14057032 |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000252374 | TF binding region |
ENSG00000006468 | chromatin interactions |
ENSG00000252374 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191895308 | chr7:14053544-14053545 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs551148594 | chr7:14053554-14053555 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs372790197 | chr7:14053558-14053559 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs567759430 | chr7:14053581-14053582 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs536908500 | chr7:14053681-14053682 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs553727510 | chr7:14053726-14053727 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs182616230 | chr7:14053730-14053731 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs538191943 | chr7:14053761-14053762 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs140300195 | chr7:14053781-14053782 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs575805622 | chr7:14053787-14053788 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs544383955 | chr7:14053794-14053795 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs186888749 | chr7:14053796-14053797 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs192787539 | chr7:14053855-14053856 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs73056087 | chr7:14053875-14053876 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs142112356 | chr7:14053877-14053878 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs554803486 | chr7:14053971-14053972 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs559992031 | chr7:14053993-14053994 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs147281756 | chr7:14053997-14053998 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs184331542 | chr7:14054009-14054010 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs551745639 | chr7:14054017-14054018 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs562188926 | chr7:14054104-14054105 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs531386866 | chr7:14054118-14054119 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs547988179 | chr7:14054157-14054158 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs189210364 | chr7:14054190-14054191 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs536426150 | chr7:14054216-14054217 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs547250993 | chr7:14054253-14054254 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs554054182 | chr7:14054270-14054271 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs567165360 | chr7:14054275-14054276 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs9886363 | chr7:14054288-14054289 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs549701328 | chr7:14054300-14054301 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs374843278 | chr7:14054354-14054355 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs544768054 | chr7:14054374-14054375 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs575559679 | chr7:14054383-14054384 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs538303357 | chr7:14054384-14054385 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs368637408 | chr7:14054388-14054389 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs193104207 | chr7:14054416-14054417 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs375477604 | chr7:14054439-14054440 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs574903497 | chr7:14054465-14054466 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs540021346 | chr7:14054470-14054471 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs368510648 | chr7:14054475-14054476 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs559955871 | chr7:14054495-14054496 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs150755713 | chr7:14054517-14054518 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs371603027 | chr7:14054523-14054524 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs184723169 | chr7:14054648-14054649 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs115322118 | chr7:14054684-14054685 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs189156641 | chr7:14054760-14054761 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs548198232 | chr7:14054814-14054815 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs200538921 | chr7:14054816-14054817 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs561614643 | chr7:14054828-14054829 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs527424989 | chr7:14054833-14054834 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:14050200-14070800 | Weak transcription | K562 | blood |
2 | chr7:14053200-14054400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr7:14054400-14059800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr7:14056200-14057000 | Enhancers | Osteobl | bone |
5 | chr7:14056400-14056800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr7:14056400-14057000 | Enhancers | Fetal Heart | heart |
7 | chr7:14056400-14057400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr7:14056800-14057000 | Enhancers | HSMMtube | muscle |
9 | chr7:14057000-14060200 | Weak transcription | Osteobl | bone |